EUVIMEDEUVIMED entdecken
Crossref

Comparative efficacy and safety of B-TUVP vs. B-TURP for benign prostatic hyperplasia at a tertiary centre in eastern Nepal

Amit Kumar Shah, Sumit Verma, Shrijan Kharel, Deepak Pun, Bashu Dev Baskota

Journal of Chitwan Medical College · 09.03.2026 · 16 (1) · 90-96

DOI: 10.54530/jcmc.1833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chitwan Medical College, online erschienen am 09.03.2026. Verfasst von Amit Kumar Shah und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bipolar transurethral resection of the prostate (B-TURP) is an established surgical treatment for benign prostatic hyperplasia (BPH). Bipolar transurethral vaporization (B-TUVP) of the prostate using a button electrode has emerged as an alternative with potential safety advantages. This study compared the efficacy and safety of B-TUVP versus B-TURP in a tertiary centre in eastern Nepal.

Methods

A retrospective cohort study of BPH treated between Jan 2021 and Dec 2024 at B and C Medical College and Teaching Hospital, Birtamod, Nepal, was conducted. Ethical approval was obtained. Patients were categorized into B-TUVP and B-TURP groups. Variables included operative time, irrigation time, haemoglobin drop, hospital stay, catheterization duration, IPSS, Qmax, QOL, and PVRV. Follow-up was at 4, 8, 12, and 24 months. Data analysis was done by SPSS version 29. A p≤0.05 was considered significant.

Results

A total of 400 patients (B-TUVP n=200, B-TURP n=200) were included. Baseline characteristics were comparable between groups. B-TUVP had longer operative time (60.94±18.64 vs 49.85±9.35 min, p=0.001) but shorter postoperative irrigation time (11.03±0.82 vs 14.99±2.02 h, p=0.001), less haemoglobin drop (0.74±0.14 vs 0.99±0.11 g/dL, p=0.001), shorter hospital stay (2.93±0.83 vs 3.50±1.10 days, p=0.001) and catheterization duration (3.03±0.84 vs 3.99±1.35 days, p=0.001). IPSS and Qmax improved significantly in both groups, with B-TURP showing better early outcomes. Long-term outcomes at 24 months were comparable in QOL, PVRV, and complication rates.

Conclusions

B-TUVP is a safe and effective alternative to B-TURP for surgical management of benign prostatic hyperplasia, offering favourable perioperative outcomes with comparable long-term efficacy.

Zitieren

APA

Shah, A. K., Verma, S., Kharel, S., Pun, D., & Baskota, B. D. (2026). Comparative efficacy and safety of B-TUVP vs. B-TURP for benign prostatic hyperplasia at a tertiary centre in eastern Nepal. Journal of Chitwan Medical College, 16(1), 90-96. https://doi.org/10.54530/jcmc.1833

Vancouver

Shah AK, Verma S, Kharel S, Pun D, Baskota BD. Comparative efficacy and safety of B-TUVP vs. B-TURP for benign prostatic hyperplasia at a tertiary centre in eastern Nepal. Journal of Chitwan Medical College. 2026;16(1):90-96. doi:10.54530/jcmc.1833

BibTeX
@article{Shah2026,
  author = {Shah, Amit Kumar and Verma, Sumit and Kharel, Shrijan and Pun, Deepak and Baskota, Bashu Dev},
  title = {Comparative efficacy and safety of B-TUVP vs. B-TURP for benign prostatic hyperplasia at a tertiary centre in eastern Nepal},
  journal = {Journal of Chitwan Medical College},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {90--96},
  doi = {10.54530/jcmc.1833}
}
Kostenlos starten →